Tsudo M, Uchiyama T, Uchino H, Yodoi J
Blood. 1983 May;61(5):1014-6.
Anti-Tac monoclonal antibody, which blocks the membrane binding and action of human T-cell growth factor (TCGF), is strongly proposed to recognize TCGF receptor. We have demonstrated that anti-Tac antibody reacted with leukemic cells from patients with adult T-cell leukemia (ATL) and reacted with T-cell lines established from ATL cells. Although antigenic modulation, or down-regulation, of Tac antigen on activated normal T cells was induced by anti-Tac antibody, the expression of Tac antigen on ATL cells or T-cell lines was not affected when examined by the fluorescence-activated cell sorter (FACS) and the radioassay using 125I-staphylococcal protein A. These results indicate that regulation of Tac antigen-TCGF receptor is different between normal and malignant T cells, suggesting that failure of down-regulation of Tac antigen on leukemic cells by anti-Tac antibody may play an important role in the malignant proliferation of ATL cells.
抗 Tac 单克隆抗体可阻断人 T 细胞生长因子(TCGF)的膜结合及作用,强烈提示其可识别 TCGF 受体。我们已证明抗 Tac 抗体可与成人 T 细胞白血病(ATL)患者的白血病细胞发生反应,并与由 ATL 细胞建立的 T 细胞系发生反应。尽管抗 Tac 抗体可诱导活化的正常 T 细胞上 Tac 抗原的抗原调变或下调,但通过荧光激活细胞分选仪(FACS)和使用 125I-葡萄球菌蛋白 A 的放射测定法检测时,ATL 细胞或 T 细胞系上 Tac 抗原的表达并未受到影响。这些结果表明,正常 T 细胞与恶性 T 细胞之间 Tac 抗原-TCGF 受体的调节存在差异,提示抗 Tac 抗体不能使白血病细胞上的 Tac 抗原下调可能在 ATL 细胞的恶性增殖中起重要作用。